Skip to main content
$86.26 $0.84 (1.0%)

01:00 PM EST on 11/25/22

Gilead Sciences, Inc. (NASDAQ:GILD)

CAPS Rating: 4 out of 5

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

Current Price $86.26 Mkt Cap $108.2B
Open $85.04 P/E Ratio 23.99
Prev. Close $86.26 Div. (Yield) $2.92 (3.4%)
Daily Range $84.76 - $86.41 Volume 4,028,739
52-Wk Range $57.17 - $86.41 Avg. Daily Vol. 8,299,458

Caps

How do you think NASDAQ:GILD will perform against the market?

Add Stock to CAPS Watchlist

All Players

3,344 Outperform
90 Underperform
 

All-Star Players

637 Outperform
9 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:GILD Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Katstu5860 (59.58)
Submitted March 10, 2022

Large moat industry with modest inflationary protection with above market dividends

CMFTomato (49.82)
Submitted September 04, 2020

I have a real hard time imagining that Gilead will have sold enough Remdesivir to make this stock a market performer much less a market *beater.* I do continue to own shares in my real portfolio though, so I'm happy to be proven wrong. Underperform.

Recent Community Commentary

Read the most recent pitches from players about GILD.

Recs

1
Member Avatar Katstu5860 (59.58) Submitted: 3/10/2022 4:15:14 PM : Outperform Start Price: $56.94 NASDAQ:GILD Score: +57.51

Large moat industry with modest inflationary protection with above market dividends

Recs

1
Member Avatar spainDC (43.98) Submitted: 2/25/2022 5:16:09 PM : Outperform Start Price: $59.46 NASDAQ:GILD Score: +51.94

good quality and value

Recs

1
Member Avatar TMFjimhalley (23.88) Submitted: 4/16/2021 11:47:44 PM : Outperform Start Price: $63.81 NASDAQ:GILD Score: +38.53

Despite declining HIV drug sales, the company's growing oncology pipeline will help it increase revenue.

Leaderboard

Find the members with the highest scoring picks in GILD.

Score Leader

BrianMotleyFool

BrianMotleyFool (70.37) Score: +536.73

The Score Leader is the player with the highest score across all their picks in GILD.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
JSergeant 73.64 7/3/2006 Outperform 3Y $12.01 +618.39% +236.35% +382.04 0 Comment
WilliamCrook2003 71.86 1/29/2007 1/25/2012 Outperform 5Y $12.68 +580.32% +200.33% +379.98 1 Comment
UrineLuck73 < 20 1/29/2007 Outperform NS $12.68 +580.32% +200.33% +379.98 0 Comment
predragj 45.14 1/30/2007 Outperform NS $12.84 +571.70% +199.99% +371.71 0 Comment
mxdfool < 20 12/15/2006 Outperform 5Y $12.90 +568.63% +198.96% +369.67 0 Comment
betsypurcell < 20 1/24/2007 Outperform NS $12.92 +567.70% +198.69% +369.01 0 Comment
rmarinchek < 20 1/25/2007 Outperform 3W $13.02 +562.69% +196.88% +365.81 0 Comment
Redskins2k9 < 20 1/25/2007 Outperform 5Y $13.02 +562.69% +196.88% +365.81 0 Comment
opveiby 78.00 1/25/2007 Outperform 5Y $13.02 +562.69% +196.88% +365.81 0 Comment
jer8899 73.03 1/23/2007 Outperform NS $12.99 +564.15% +198.73% +365.42 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for GILD.